英菲格拉替尼能与食物同服吗?使用时要注意什么
Infigratinib is an oral drug, which greatly enhances the convenience of use and increases patient compliance. Infigratinib does not directly target the FGF23 factor, but addresses FGFR1 downstream of the FGF23 factor. Can it be taken with food? What should I pay attention to when using it?
How to use Infigratinib
Infigratinib should be taken at the same time every day, at least 1 hour before meals or 2 hours after meals. It needs to be taken on an empty stomach. When taking the medication, patients should swallow the entire capsule with a glass of water and should not crush, chew, or dissolve the capsule.
The recommended dose of Infigratinib is: 125 mg, taken orally once a day, for 21 days of continuous use and 7 days of drug withdrawal, with a 28-day treatment cycle. The actual medication can be adjusted according to the patient's physical condition, but the patient cannot blindly increase or decrease the dosage of Infigratinib, because this may cause adverse reactions, and the patient should strictly follow the doctor's diagnosis and treatment recommendations.
Infigratinib Precautions
Infigratinib is ocularly toxic, and treatment with this drug may cause retinal pigment epithelial detachment. Therefore, patients should undergo a comprehensive eye examination before receiving treatment with this drug and at 1 month, 3 months and every 3 months thereafter. Patients with serious conditions should communicate with their doctors in a timely manner, and patients should not self-medicate.
Treatment with Infigratinib may lead to hyperphosphatemia and soft tissue mineralization, leading to non-uremic calcinosis, soft tissue mineralization, cutaneous calcinosis, vascular calcification, myocardial calcification and other conditions. Depending on its severity, patients may need to consider stopping, reducing their dose, or permanently discontinuing treatment with Infigratinib.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended hot articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)